-
Mashup Score: 1
The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.
Source: www.infectiousdiseaseadvisor.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 1
The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.
Source: www.infectiousdiseaseadvisor.comCategories: General Medicine News, Infectious DiseaseTweet-
Among people with mild infection during the #Delta and #Omicron variant-dominant periods, #vaccination against #COVID19 was protective against the development of post-COVID conditions. ⬇️ https://t.co/J7EQaksdKK
-
-
Mashup Score: 1
Long COVID prevalence and burden continue to decrease among health care workers however, some still experience everyday life restrictions.
Source: www.infectiousdiseaseadvisor.comCategories: General Medicine News, Infectious DiseaseTweet-
Among a population of previously healthy #healthcareworkers, the prevalence and burden of #longCOVID continued to decrease over the course of 30 months. ⬇️ https://t.co/cQEJ35eqwS
-
-
Mashup Score: 0
T cruzi infection remains a concern among US transplant candidates, underscoring the need for expanded screening and awareness of Chagas disease.
Source: www.infectiousdiseaseadvisor.comCategories: General Medicine News, Infectious DiseaseTweet-
The prevalence of #Trypanosomacruzi infection continues to rise, especially among non-Hispanic individuals. ⬇️ https://t.co/ahl8BkbG3B
-
-
Mashup Score: 0
The pediatric BNT162b2 vaccine is safe among children aged between 5 and 11 years with and without comorbidities.
Source: www.infectiousdiseaseadvisor.comCategories: General Medicine News, Infectious DiseaseTweet-
#Children aged 5 to 11 years with vs without #comorbidities reported a higher rate of postvaccination symptoms following receipt of the #BNT162b2vaccine. #pediatrics #covid #covid19 #covidvaccine ⬇️ https://t.co/PbbXTGxruq
-
-
Mashup Score: 0
T cruzi infection remains a concern among US transplant candidates, underscoring the need for expanded screening and awareness of Chagas disease.
Source: www.infectiousdiseaseadvisor.comCategories: General Medicine News, Infectious DiseaseTweet-
The prevalence of #Trypanosomacruzi infection continues to rise, especially among non-Hispanic individuals. ⬇️ https://t.co/ahl8BkbG3B
-
-
Mashup Score: 0Children Undergoing ECMO Are at High Risk for Nosocomial Infection - 1 month(s) ago
Children undergoing ECMO are at a high risk for nosocomial infection; however, nosocomial infection did not increase mortality risk.
Source: www.infectiousdiseaseadvisor.comCategories: General Medicine News, Infectious DiseaseTweet-
#Nosocomialinfection is prevalent among #pediatricpatients undergoing extracorporeal membrane oxygenation. #ECMO ⬇️ https://t.co/sUfdRUKYHV
-
-
Mashup Score: 0
Robust and comparable immunogenicity was observed between adolescents and young adults who received 2- or 3-dose schedules of 4CMenB vaccination.
Source: www.infectiousdiseaseadvisor.comCategories: General Medicine News, Infectious DiseaseTweet-
No differences in breadth of immune response or immunogenicity were observed between #adolescents and #youngeradults who received 2- vs 3-dose schedules of the #meningococcalserogroupB #vaccine. #4CMenB ⬇️ https://t.co/DwXbWFYlZT
-
-
Mashup Score: 0Children Undergoing ECMO Are at High Risk for Nosocomial Infection - 1 month(s) ago
Children undergoing ECMO are at a high risk for nosocomial infection; however, nosocomial infection did not increase mortality risk.
Source: www.infectiousdiseaseadvisor.comCategories: General Medicine News, Infectious DiseaseTweet-
#Nosocomialinfection is prevalent among #pediatricpatients undergoing extracorporeal membrane oxygenation. #ECMO ⬇️ https://t.co/sUfdRUKYHV
-
-
Mashup Score: 0
Robust and comparable immunogenicity was observed between adolescents and young adults who received 2- or 3-dose schedules of 4CMenB vaccination.
Source: www.infectiousdiseaseadvisor.comCategories: General Medicine News, Infectious DiseaseTweet-
No differences in breadth of immune response or immunogenicity were observed between #adolescents and #youngeradults who received 2- vs 3-dose schedules of the #meningococcalserogroupB #vaccine. #4CMenB ⬇️ https://t.co/DwXbWFYlZT
-
Among people with mild infection during the #Delta and #Omicron variant-dominant periods, #vaccination against #COVID19 was protective against the development of post-COVID conditions. ⬇️ https://t.co/J7EQaksdKK